JPWO2019230856A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019230856A5 JPWO2019230856A5 JP2020522575A JP2020522575A JPWO2019230856A5 JP WO2019230856 A5 JPWO2019230856 A5 JP WO2019230856A5 JP 2020522575 A JP2020522575 A JP 2020522575A JP 2020522575 A JP2020522575 A JP 2020522575A JP WO2019230856 A5 JPWO2019230856 A5 JP WO2019230856A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- deleted
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 194
- 150000001413 amino acids Chemical class 0.000 claims 53
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 claims 7
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 6
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 6
- 102000040430 polynucleotide Human genes 0.000 claims 3
- 108091033319 polynucleotide Proteins 0.000 claims 3
- 239000002157 polynucleotide Substances 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 101000654386 Homo sapiens Sodium channel protein type 9 subunit alpha Proteins 0.000 claims 1
- 208000003251 Pruritus Diseases 0.000 claims 1
- 102100031367 Sodium channel protein type 9 subunit alpha Human genes 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000013604 expression vector Substances 0.000 claims 1
- 230000003449 preventive effect Effects 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018104391 | 2018-05-31 | ||
| JP2018104391 | 2018-05-31 | ||
| PCT/JP2019/021444 WO2019230856A1 (ja) | 2018-05-31 | 2019-05-30 | Ｎａｖ１．７モノクローナル抗体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2019230856A1 JPWO2019230856A1 (ja) | 2021-06-24 |
| JPWO2019230856A5 true JPWO2019230856A5 (es) | 2022-06-06 |
Family
ID=68697272
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020522575A Pending JPWO2019230856A1 (ja) | 2018-05-31 | 2019-05-30 | Ｎａｖ１．７モノクローナル抗体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11643458B2 (es) |
| EP (1) | EP3805390A4 (es) |
| JP (1) | JPWO2019230856A1 (es) |
| KR (1) | KR20210015898A (es) |
| CN (1) | CN112368383A (es) |
| AU (1) | AU2019277546A1 (es) |
| BR (1) | BR112020024005A2 (es) |
| CA (1) | CA3102060A1 (es) |
| MX (1) | MX2020012678A (es) |
| WO (1) | WO2019230856A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3794036A4 (en) * | 2018-05-18 | 2022-07-27 | National Research Council of Canada | ANTIBODIES AND ANTIBODY FRAGMENTS AGAINST THE HNAV1.7 CHANNEL AND THEIR USE IN INDICATIONS OF PAIN AND CANCER |
| WO2022241752A1 (zh) * | 2021-05-21 | 2022-11-24 | 易森荟(武汉)生物医药有限公司 | 特异结合电压门控钠离子通道α亚基Nav1.7的抗体或抗体片段 |
| CA3236404A1 (en) | 2021-11-01 | 2023-05-04 | Mai YOSHIKAWA | Novel nav1.7 monoclonal antibody |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0729976A1 (en) | 1993-11-19 | 1996-09-04 | Chugai Seiyaku Kabushiki Kaisha | Reconstituted human antibody against human medulloblastomatous cell |
| KR100261941B1 (ko) | 1994-07-13 | 2000-07-15 | 나가야마 오사무 | 사람의 인터루킨-8에 대한 재구성 사람항체 |
| AU744146B2 (en) | 1996-09-26 | 2002-02-14 | Chugai Seiyaku Kabushiki Kaisha | Antibody against human parathormone related peptides |
| CN102781963B (zh) | 2009-10-27 | 2018-02-16 | Ucb医药有限公司 | 功能修饰性NAv1.7抗体 |
| EA201591754A1 (ru) | 2013-03-14 | 2016-01-29 | Ридженерон Фармасьютикалз, Инк. | Человеческие антитела к na1.7 |
| GB2517953A (en) * | 2013-09-05 | 2015-03-11 | Argen X Bv | Antibodies to complex targets |
| EP3041869A1 (en) | 2013-09-05 | 2016-07-13 | Duke University | Nav1.7 antibodies and methods of using the same |
-
2019
- 2019-05-30 KR KR1020207037235A patent/KR20210015898A/ko not_active Application Discontinuation
- 2019-05-30 US US17/059,886 patent/US11643458B2/en active Active
- 2019-05-30 JP JP2020522575A patent/JPWO2019230856A1/ja active Pending
- 2019-05-30 MX MX2020012678A patent/MX2020012678A/es unknown
- 2019-05-30 EP EP19812189.9A patent/EP3805390A4/en not_active Withdrawn
- 2019-05-30 CA CA3102060A patent/CA3102060A1/en active Pending
- 2019-05-30 WO PCT/JP2019/021444 patent/WO2019230856A1/ja unknown
- 2019-05-30 CN CN201980044105.8A patent/CN112368383A/zh active Pending
- 2019-05-30 BR BR112020024005-2A patent/BR112020024005A2/pt unknown
- 2019-05-30 AU AU2019277546A patent/AU2019277546A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2019230856A5 (es) | ||
| RU2505603C2 (ru) | Антитело против рецептора il-6 | |
| EA201991099A1 (ru) | Антитела против cd73 и их применение | |
| JP2020515508A5 (es) | ||
| HRP20201503T1 (hr) | MOLEKULE SA SPECIFIČNOŠĆU ZA CD45 i CD79 | |
| JP2016529229A5 (es) | ||
| RU2017102193A (ru) | Конструкции полиспецифических антител | |
| RU2019118359A (ru) | Антитело к cd73 человека | |
| JP2017529097A5 (es) | ||
| JP2019503990A5 (es) | ||
| PE20181363A1 (es) | Variantes optimizadas de anticuerpos anti-vegf | |
| JP2020537644A5 (es) | ||
| JP2017528117A5 (es) | ||
| RU2017104815A (ru) | Молекулы со специфичностью в отношении cd79 и cd22 | |
| JP2017529870A5 (es) | ||
| NZ602780A (en) | Human antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereof | |
| CL2010001544A1 (es) | Anticuerpo monoclonal humanizado o fragmento de union al mismo que se une y neutraliza al factor de crecimiento endotelial vascular humano (hvegf); composicion que lo comprende; acido nucleico codificante; vector; celula huesped; su uso para tratar o prevenir una enfermedad mediada por vegf; e hibridoma. | |
| JP2015509948A5 (es) | ||
| RS54259B1 (en) | HAVE AUTOANTITELA ACHIEVEMENTS | |
| JP2016512214A5 (es) | ||
| AR109533A2 (es) | Anticuerpos anti-fractalkina o un fragmento de unión a la fkn de éste, composiciones que lo comprenden y métodos para tratar trastornos inflamatorios | |
| WO2017060322A3 (en) | Ptefb-inhibitor-adc | |
| JP2021502984A5 (es) | ||
| PE20220568A1 (es) | Moleculas de union a cd19 y usos de las mismas | |
| PE20181956A1 (es) | Polipeptidos que inhiben cd40l |